Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate is a complex organic molecule that features a nitrophenyl group, a piperidine-1-carboxylate group, and an imidazo[4,5-b]pyridin-1-yl group. 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate is notable for its unique structure and potential pharmacological activities, which make it a promising candidate for pharmaceutical research and development. Additionally, its properties could render it suitable for use in organic synthesis as a building block for constructing more complex molecules.

1190363-91-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1190363-91-7 Structure
  • Basic information

    1. Product Name: 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate
    2. Synonyms: 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate
    3. CAS NO:1190363-91-7
    4. Molecular Formula:
    5. Molecular Weight: 383.363
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1190363-91-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate(1190363-91-7)
    11. EPA Substance Registry System: 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate(1190363-91-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1190363-91-7(Hazardous Substances Data)

1190363-91-7 Usage

Uses

Used in Pharmaceutical Research and Development:
4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate is used as a research compound for its potential pharmacological activities. Its unique structure may contribute to the development of new drugs targeting various therapeutic areas.
Used in Organic Synthesis:
In the field of organic synthesis, 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate is used as a building block for constructing more complex molecules. Its properties and reactivity can be leveraged to create novel compounds with specific functions and applications.
Further research is necessary to fully understand the potential uses and properties of 4-nitrophenyl 4-(2,3-dihydro-2-oxoimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate, as its current applications are based on its unique structure and potential.

Check Digit Verification of cas no

The CAS Registry Mumber 1190363-91-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,3,6 and 3 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1190363-91:
(9*1)+(8*1)+(7*9)+(6*0)+(5*3)+(4*6)+(3*3)+(2*9)+(1*1)=147
147 % 10 = 7
So 1190363-91-7 is a valid CAS Registry Number.

1190363-91-7Downstream Products

1190363-91-7Relevant articles and documents

Calcitonin gene-related peptide (CGRP) receptor antagonists: Pyridine as a replacement for a core amide group

Luo, Guanglin,Chen, Ling,Civiello, Rita,Pin, Sokhom S.,Xu, Cen,Kostich, Walter,Kelley, Michelle,Conway, Charles M.,MacOr, John E.,Dubowchik, Gene M.

scheme or table, p. 2917 - 2921 (2012/06/04)

In our continuing efforts to identify CGRP receptor antagonists that can be dosed orally for the treatment of migraine headache, we have investigated a pyridine bioisosteric replacement of a polar amide portion of a previous lead compound, BMS-694153. Pyr

CGRP Receptor Antagonists

-

Page/Page column 46-47, (2009/10/21)

The disclosure generally relates to the novel compounds of formula I, including their salts, which are CGRP receptor antagonists. The disclosure also relates to pharmaceutical compositions and methods for using the compounds in the treatment of CGRP related disorders including migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases such as asthma, and chronic obstructive pulmonary disease (COPD).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1190363-91-7